Hartnup disease
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Hartnup disease Classification and external resources | |
| Tryptophan | |
| ICD-10 | E72.0 |
| ICD-9 | 270.0 |
| OMIM | 234500 |
| DiseasesDB | 5638 |
| eMedicine | derm/713 |
| MeSH | D006250 |
|
WikiDoc Resources for Hartnup disease | |
|
Articles | |
|---|---|
|
Most recent articles on Hartnup disease Most cited articles on Hartnup disease | |
|
Media | |
|
Powerpoint slides on Hartnup disease | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Hartnup disease at Clinical Trials.gov Trial results on Hartnup disease Clinical Trials on Hartnup disease at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Hartnup disease NICE Guidance on Hartnup disease
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Hartnup disease Discussion groups on Hartnup disease Patient Handouts on Hartnup disease Directions to Hospitals Treating Hartnup disease Risk calculators and risk factors for Hartnup disease
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Hartnup disease | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Business | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Hartnup disease, or Hartnup's disease, or Hartnup disorder, is an autosomal recessive genetic metabolic disorder in the absorption of the amino acid tryptophan that can be, in turn, converted into Serotonin, Melatonin and Niacin. Niacin is a precursor to nicotinamide, a necessary component of NAD+.
The causative gene is located on chromosome 5.
Symptoms
Hartnup disease manifest during infancy with variable clinical presentation: failure to thrive, photosensitivity, intermittent ataxia, nystagmus and tremor. Nicotinamide is necessary for neutral amino acid transporter production in the proximal renal tubules found in the kidney, and intestinal mucosal cells found in the small intestine. Therefore, a symptom stemming from this disorder results in increased amounts of amino acids in the urine.
Pellagra is also caused by low nicotinamide; this disorder results in dermatitis, diarrhea and dementia.
See also
External links
de:Hartnup-KrankheitAcknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .

